Oncozenge AB Financial Flexibility Index

Latest as of December 2025: 0.37x

Oncozenge AB financial flexibility index. Oncozenge AB (ONCOZ) has a Financial Flexibility Index of 0.37x as of December 2025. Free cash flow of Skr5.82 Million (operating CF Skr-7.24 Million minus capex Skr13.06 Million) represents 0% of total liabilities (Skr15.92 Million). See Oncozenge AB (ONCOZ) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Financial Flexibility Index

0.37x
Free Cash Flow / Total Liabilities

Free Cash Flow

Skr5.82 Million
Operating CF − Capex

Total Liabilities

Skr15.92 Million
SEK

Capital Expenditures

Skr13.06 Million
SEK

Financial Flexibility Index of Oncozenge AB (2020–2025)

Financial flexibility index of Oncozenge AB from 2020 to 2025. Historical Financial Flexibility Index trend for Oncozenge AB across 6 annual periods. Check ONCOZ cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Oncozenge AB Financial Flexibility Index by Year (2020–2025)

Oncozenge AB financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Oncozenge AB. For the full cash flow conversion analysis, see ONCOZ cash flow metrics.

Year Flexibility Index Free Cash Flow (SEK) Operating CF Total Liabilities YoY Change
2025 0.00x Skr0.00 Skr-13.06 Million Skr15.92 Million ▲ +100.0%
2024 -5.91x Skr-8.76 Million Skr-8.76 Million Skr1.48 Million ▲ +41.3%
2023 -10.05x Skr-17.08 Million Skr-17.08 Million Skr1.70 Million ▼ -33.0%
2022 -7.56x Skr-22.08 Million Skr-22.08 Million Skr2.92 Million ▼ -6395.2%
2021 0.12x Skr589.00K Skr-4.77 Million Skr4.90 Million ▲ +108363.6%
2020 0.00x Skr-1.00K Skr-1.00K Skr9.01 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities